Serum Amyloid A1 As a Biomarker for Radiation Dose Estimation and Lethality Prediction in Irradiated Mouse

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2020 Feb 12

PMID 32042731

Citations 9

Authors

Jinfeng Huang

Zhenhua Qi

Min Chen

Ting Xiao

Jian Guan

Meijuan Zhou

Qi Wang

Zhongwu Lin

Zhidong Wang

Affiliations

Soon will be listed here.

Abstract

Background: Fast and reliable biomarkers are needed to distinguish whether individuals were exposed or not to radiation and assess radiation dose, and to predict the severity of radiation damage in a large-scale radiation accident. Serum amyloid A1 (SAA1) is a protein induced by multiple factors including inflammatory. Therefore, this study aimed at exploring the role of SAA1 in the radiation dose estimation and lethality prediction after radiation.

Methods: C57BL/6J female mice were exposed to total body irradiation (TBI) at different doses and time points and amifostine, a drug used to reduce the side effects of radiotherapy, was injected before irradiation. Patients with nasopharyngeal carcinoma subjected to radiotherapy were used as the irradiation model in humans.

Results: A moderate SAA1 increase was observed at 6 hours in serum samples from irradiated mice at all doses used, with a peak at 12 hours, then decreased to day 3 after exposure. A second SAA1 increase was observed from day 5 to 7, which was associated to subsequent lethality. Treatment with amifostine before irradiation could prevent mice death and inhibit the second SAA1 increase. SAA1 increase after radiation was confirmed in human serum of nasopharyngeal carcinoma patients after radiotherapy.

Conclusions: Serum SAA1 levels could represent a biomarker for radiation dose estimation and its second increase might be a useful lethality indicator after radiation in a mouse model.

Citing Articles

The Role of Neuroinflammation in Shaping Neuroplasticity and Recovery Outcomes Following Traumatic Brain Injury: A Systematic Review.

Calderone A, Latella D, Cardile D, Gangemi A, Corallo F, Rifici C Int J Mol Sci. 2024; 25(21).

PMID: 39519259 PMC: 11546226. DOI: 10.3390/ijms252111708.

Ionising radiation exposure-induced regulation of selected biomarkers and their impact in cancer and treatment.

Mzizi Y, Mbambara S, Moetlhoa B, Mahapane J, Mdanda S, Sathekge M Front Nucl Med. 2024; 4:1469897.

PMID: 39498386 PMC: 11532091. DOI: 10.3389/fnume.2024.1469897.

Effects of Recombinant α-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to Lu-Octreotate.

Ytterbrink C, Shubbar E, Parris T, Langen B, Druid M, Schuler E Int J Mol Sci. 2024; 25(13).

PMID: 39000587 PMC: 11242497. DOI: 10.3390/ijms25137480.

Serum sSelectin-L is an early specific indicator of radiation injury.

Li S, Zhang W, Zhang H, Fan Y, Jia M, Qi Z Heliyon. 2024; 10(10):e30527.

PMID: 38778981 PMC: 11109730. DOI: 10.1016/j.heliyon.2024.e30527.

BPIFA2 as a Novel Early Biomarker to Identify Fatal Radiation Injury After Radiation Exposure.

He L, Zhou S, Li W, Wang Q, Qi Z, Zhou P Dose Response. 2022; 20(1):15593258221086478.

PMID: 35431693 PMC: 9006374. DOI: 10.1177/15593258221086478.

References

Sun L, Ye R . Serum amyloid A1: Structure, function and gene polymorphism. Gene. 2016; 583(1):48-57. PMC: 5683722. DOI: 10.1016/j.gene.2016.02.044. View

Thomas-Ruddel D, Poidinger B, Kott M, Weiss M, Reinhart K, Bloos F . Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit Care. 2018; 22(1):128. PMC: 5949148. DOI: 10.1186/s13054-018-2050-9. View

Xu Z, Yan Y, Xiao L, Dai S, Zeng S, Qian L . Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway. PLoS One. 2017; 12(4):e0175977. PMC: 5393875. DOI: 10.1371/journal.pone.0175977. View

Ahmad S, Tejuja A, Newman K, Zarychanski R, Seely A . Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Crit Care. 2009; 13(6):232. PMC: 2811891. DOI: 10.1186/cc8132. View

Pierrakos C, Vincent J . Sepsis biomarkers: a review. Crit Care. 2010; 14(1):R15. PMC: 2875530. DOI: 10.1186/cc8872. View

Pernot E, Hall J, Baatout S, Benotmane M, Blanchardon E, Bouffler S . Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res. 2012; 751(2):258-286. DOI: 10.1016/j.mrrev.2012.05.003. View

Waselenko J, MacVittie T, Blakely W, Pesik N, Wiley A, Dickerson W . Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 2004; 140(12):1037-51. DOI: 10.7326/0003-4819-140-12-200406150-00015. View

Dainiak N, Gent R, Carr Z, Schneider R, Bader J, Buglova E . Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep. 2011; 5(3):183-201. PMC: 3638239. DOI: 10.1001/dmp.2011.73. View

Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, Godson C . Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol. 2010; 184(11):6427-37. DOI: 10.4049/jimmunol.0902941. View

10.

Goans R, Holloway E, Berger M, Ricks R . Early dose assessment following severe radiation accidents. Health Phys. 1997; 72(4):513-8. DOI: 10.1097/00004032-199704000-00001. View

11.

Coeytaux K, Bey E, Christensen D, Glassman E, Murdock B, Doucet C . Reported radiation overexposure accidents worldwide, 1980-2013: a systematic review. PLoS One. 2015; 10(3):e0118709. PMC: 4366065. DOI: 10.1371/journal.pone.0118709. View

12.

Ossetrova N, Sandgren D, Blakely W . Protein biomarkers for enhancement of radiation dose and injury assessment in nonhuman primate total-body irradiation model. Radiat Prot Dosimetry. 2014; 159(1-4):61-76. DOI: 10.1093/rpd/ncu165. View

13.

Jensen L, WHITEHEAD A . Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J. 1998; 334 ( Pt 3):489-503. PMC: 1219714. DOI: 10.1042/bj3340489. View

14.

Anno G, BAUM S, Withers H, Young R . Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Health Phys. 1989; 56(6):821-38. DOI: 10.1097/00004032-198906000-00001. View

15.

Kaur A, Ten Have G, Hritzo B, Deutz N, Olsen C, Moroni M . Morphological and functional impairment in the gut in a partial body irradiation minipig model of GI-ARS. Int J Radiat Biol. 2018; 96(1):112-128. DOI: 10.1080/09553002.2018.1552377. View

16.

Roch-Lefevre S, Mandina T, Voisin P, Gaetan G, Gonzalez Mesa J, Valente M . Quantification of gamma-H2AX foci in human lymphocytes: a method for biological dosimetry after ionizing radiation exposure. Radiat Res. 2010; 174(2):185-94. DOI: 10.1667/RR1775.1. View

17.

Pereira de Lemos Pinto M, Santos N, Amaral A . Current status of biodosimetry based on standard cytogenetic methods. Radiat Environ Biophys. 2010; 49(4):567-81. DOI: 10.1007/s00411-010-0311-3. View

18.

Goans R, Holloway E, Berger M, Ricks R . Early dose assessment in criticality accidents. Health Phys. 2001; 81(4):446-9. DOI: 10.1097/00004032-200110000-00009. View

19.

Zhou D, Yu T, Chen G, Brown S, Yu Z, Mattson M . Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo. Int J Radiat Biol. 2001; 77(7):763-72. DOI: 10.1080/09553000110050047. View

20.

Gluzman-Poltorak Z, Mendonca S, Vainstein V, Kha H, Basile L . Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation. J Hematol Oncol. 2014; 7:31. PMC: 4108131. DOI: 10.1186/1756-8722-7-31. View